Search Results - "SLOAND, Elaine M"

Refine Results
  1. 1

    Factors Affecting Response and Survival in Patients With Myelodysplasia Treated With Immunosuppressive Therapy by SLOAND, Elaine M, WU, Colin O, GREENBERG, Peter, YOUNG, Neal, BARRETT, John

    Published in Journal of clinical oncology (20-05-2008)
    “…Marrow failure in some patients with myelodysplastic syndrome (MDS) responds to immunosuppressive treatment (IST), but long-term outcome after IST has not been…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study by Scheinberg, Phillip, Wu, Colin O, Nunez, Olga, Scheinberg, Priscila, Boss, Carol, Sloand, Elaine M, Young, Neal S

    Published in Haematologica (Roma) (01-03-2009)
    “…1 Hematology Branch and 2 Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA…”
    Get full text
    Journal Article
  4. 4

    The Role of the Immune System in Myelodysplasia: Implications for Therapy by Sloand, Elaine M, Rezvani, Katayoun

    Published in Seminars in hematology (2008)
    “…Patients with myelodysplastic syndrome (MDS) have intrinsic, usually acquired genetic defects in their hematopoietic stem cells, but some others exhibit…”
    Get full text
    Journal Article
  5. 5

    Hematopoietic-specific microRNA expression in human cells by Ramkissoon, Shakti H., Mainwaring, Lori A., Ogasawara, Yoji, Keyvanfar, Keyvan, Philip McCoy, J., Sloand, Elaine M., Kajigaya, Sachiko, Young, Neal S.

    Published in Leukemia research (01-05-2006)
    “…We examined expression profiles of hematopoietic tissue-specific microRNAs (miRNAs; miR-142, miR-155, miR-181 and miR-223) in 17 commercially available…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia by Maciejewski, Jaroslaw P., Risitano, Antonio, Sloand, Elaine M., Nunez, Olga, Young, Neal S.

    Published in Blood (01-05-2002)
    “…A serious complication of aplastic anemia (AA) is its evolution to clonal hematologic diseases such as myelodysplasia (MDS) and leukemia, which is usually…”
    Get full text
    Journal Article
  8. 8

    Hypocellular Myelodysplasia by Sloand, Elaine M., MD

    “…Myelodysplasia must be considered in the differential diagnosis of patients who have bone marrow failure, but bone marrow cellularity per se may not…”
    Get full text
    Journal Article
  9. 9

    Immunosuppression for Myelodysplastic Syndrome: How Bench to Bedside to Bench Research Led to Success by Sloand, Elaine M., MD, Barrett, A.J., MD

    “…Laboratory evidence and clinical evidence suggest that some patients with myelodysplastic syndrome (MDS) have immunologically mediated disease. This article…”
    Get full text
    Journal Article
  10. 10

    Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab by SLOAND, Elaine M, OLNES, Matthew J, WEINSTEIN, Barbara, COLIN WU, MACIEJEWSKI, Jaroslaw, SCHEINBERG, Phillip, YOUNG, Neal S

    Published in Haematologica (Roma) (01-03-2010)
    “…Pure red cell aplasia and moderate aplastic anemia are marrow failure states with an immune pathogenesis. Previously, we described short-term improvements in…”
    Get full text
    Journal Article
  11. 11

    Association of Telomere Length of Peripheral Blood Leukocytes With Hematopoietic Relapse, Malignant Transformation, and Survival in Severe Aplastic Anemia by Scheinberg, Phillip, Cooper, James N, Sloand, Elaine M, Wu, Colin O, Calado, Rodrigo T, Young, Neal S

    “…CONTEXT Critically short telomeres produce apoptosis, cell senescence, and chromosomal instability in tissue culture and animal models. Variations in telomere…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Targeting Immune Dysregulation in Myelodysplastic Syndromes by Olnes, Matthew J, Sloand, Elaine M

    Published in JAMA (23-02-2011)
    “…Myelodysplastic syndromes (MDS) are a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis and a tendency to develop…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins by Sloand, Elaine M., Pfannes, Loretta, Chen, Gubin, Shah, Simant, Solomou, Elena E., Barrett, John, Young, Neal S.

    Published in Blood (15-03-2007)
    “…CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) are distinguished from other MDS cells and from normal hematopoietic cells by their…”
    Get full text
    Journal Article
  15. 15

    T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy by Sloand, Elaine M., Melenhorst, J. Joseph, Tucker, Zachary C.G., Pfannes, Loretta, Brenchley, Jason M., Yong, Agnes, Visconte, Valeria, Wu, Colin, Gostick, Emma, Scheinberg, Phillip, Olnes, Matthew J., Douek, Daniel C., Price, David A., Barrett, A. John, Young, Neal S.

    Published in Blood (03-03-2011)
    “…Clinical observations and laboratory evidence link bone marrow failure in myelodysplastic syndrome (MDS) to a T cell–mediated immune process that is responsive…”
    Get full text
    Journal Article
  16. 16

    Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia by Scheinberg, Phillip, Fischer, Steven H., Li, Li, Nunez, Olga, Wu, Colin O., Sloand, Elaine M., Cohen, Jeffrey I., Young, Neal S., John Barrett, A.

    Published in Blood (15-04-2007)
    “…The natural history of EBV and CMV reactivation and the potential for serious complications following antibody-based immunosuppressive treatment for bone…”
    Get full text
    Journal Article
  17. 17

    Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome by Sloand, Elaine M., Mainwaring, Lori, Fuhrer, Monika, Ramkissoon, Shakti, Risitano, Antonio M., Keyvanafar, Keyvan, Lu, Jun, Basu, Atanu, Barrett, A. John, Young, Neal S.

    Published in Blood (01-08-2005)
    “…Clinical observations and experimental evidence link bone marrow failure in myelodysplastic syndrome (MD33) with a T cell–dominated autoimmune process…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities by Chen, Guibin, Zeng, Weihua, Miyazato, Akira, Billings, Eric, Maciejewski, Jaroslaw P., Kajigaya, Sachiko, Sloand, Elaine M., Young, Neal S.

    Published in Blood (15-12-2004)
    “…Aneuploidy, especially monosomy 7 and trisomy 8, is a frequent cytogenetic abnormality in the myelodysplastic syndromes (MDSs). Patients with monosomy 7 and…”
    Get full text
    Journal Article
  20. 20